Citi’s 12th Annual Biotech Conference Mandarin Oriental Boston | 776 Boylston Street | Boston, MA September 6-7, 2017

Wednesday, September 6, 2017 Oriental Ballroom 1 – Arcade Level Moderator 9:00AM ** Advancing the Therapeutic Landscape in Breast Cancer Robyn Karnauskas & Puma Biotechnology (PBYI) – Alan Auerbach – CEO, President & Chairman Yigal Nochomovitz & Radius Health, Inc. (RDUS) – Gary Hattersley – Chief Scientific Officer Joel Beatty Syndax Pharmaceuticals, Inc. (SNDX) - Briggs Morrison – CEO & Director 10:00AM Chronic Kidney Disease Physician Panel Yigal Nochomovitz & David Charytan, M.D., MSc – Assistant Professor of Medicine at Harvard Medical School Joel Beatty 11:00AM ** Fireside Chat with: Gilead (GILD) Robyn Karnauskas Robin Washington – EVP & Chief Financial Officer Kevin Young CBE - Chief Operating Officer Norbert Bischofberger – EVP, R&D and Chief Scientific Officer 12:00PM ** Fireside Chat with: Bioverativ (BIVV) Lunch Location: Oriental Ballroom 2 Robyn Karnauskas & John Cox – Chief Executive Officer Mohit Bansal John Greene – Chief Financial Officer 1:00PM ** Precision Medicine in Oncology and Next Generation Diagnostics Yigal Nochomovitz & Epizyme, Inc. (EPZM) – Robert Bazemore – President & CEO Joel Beatty & Dan Foundation Medicine, Inc. (FMI) – Melanie Nallicheri – Chief Business Officer & Head of Biopharma Arias Kura Oncology, Inc. (KURA) – Troy Wilson – President & CEO Loxo Oncology (LOXO) - Josh Bilenker – Chief Executive Officer 2:00PM Emerging Innovators – An Introduction to Biotech Privates Robyn Karnauskas Therapeutics – Stephane Bancel – Chief Executive Officer Aptinyx – Norbert Riedel – Chief Executive Officer Arcus – Terry Rosen – Chief Executive Officer CureVac – Daniel L. Menichella – Chief Executive Officer (US) IDEAYA Biosciences – Yujiro Hata – Chief Executive Officer 3:00PM ** I/O Beyond PD-1: Opportunities & Challenges Yigal Nochomovitz & Aduro Biotech, Inc. (ADRO) – Andrea van Elsas – Chief Scientific Officer Joel Beatty Five Prime Therapeutics (FPRX) – Aron Knickerbocker – Chief Operating Officer Inovio Pharmaceuticals, Inc. (INO) - Joseph Kim – CEO, President & Director Mirati Therapeutics, Inc. (MRTX) – Charles Baum. – President & CEO 4:00PM Expert Take on New Therapeutics in wet-AMD Robyn Karnauskas & Elias Reichel, M.D. – Vice Chair, Director & Professor at Tufts University School of Medicine Yigal Nochomovitz Thursday, September 7, 2017 Oriental Ballroom 1 – Arcade Level Moderator 9:00AM Drug Pricing and Policy Panel Robyn Karnauskas Kim Monk – Managing Director – Capital Alpha Partners, LLC 10:00AM ** Fireside Chat with: TESARO, Inc. (TSRO) Robyn Karnauskas & Lonnie Moulder – Chief Executive Officer Mohit Bansal Mary Lynne Hedley – President & Chief Operating Officer 11:00AM ** Gene-Therapy Manufacturing and Regulatory Opportunities and Challenges Robyn Karnauskas & AveXis, Inc. (AVXS) – Sean Nolan – President & CEO & Suku Nagendran – Chief Medical Officer Mohit Bansal Regenxbio Inc. (RGNX) - Kenneth Mills – Chief Executive Officer Spark Therapeutics, Inc. (ONCE) – Jeff Marrazzo – Chief Executive Officer uniQure, Inc. (QURE) – Matt Kapusta – Chief Executive Officer 12:00PM ** Fireside Chat with: Juno Therapeutics (JUNO) Lunch Location: Oriental Ballroom 2 Robyn Karnauskas & Steve Harr – CFO & Head of Corporate Development Mohit Bansal 1:00PM KOL Take on Novel Blood Thinners and Antidotes Yigal Nochomovitz Rajat Gupta, M.D. – Preventive Cardiologist & Geneticist at Brigham and Women’s Hospital Joshua Kosowsky, M.D. – Assistant Professor of Medicine at Harvard Medical School & Clinical Director of Emergency Medicine at Brigham and Women’s Hospital **Denotes that we WILL webcast these panels only

Citi’s 12th Annual Biotech Conference Mandarin Oriental Boston | 776 Boylston Street | Boston, MA September 6-7, 2017

COMPANIES HOSTING 1x1 MEETINGS ONLY:

WEDNESDAY, SEPTEMBER 6th THURSDAY, SEPTEMBER 7th Abeona Therapeutics, Inc. (ABEO) Amarin Corp (AMRN) Acceleron Pharma (XLRN) Anthera Pharmaceuticals (ANTH) Aclaris Therapeutics (ACRS) Ardelyx, Inc. (ARDX) (ACOR) Arena Pharmaceuticals, Inc. (ARNA) Array BioPharma, Inc. (ARRY) Adaptimmune Therapeutics PLC (ADAP) Assembly Biosciences, Inc. (ASMB) PLC (ALKS) Atara Biotherapetucs, Inc. (ATRA) , Inc. (BIIB) Bellicum Pharmaceuticals, Inc. (BLCM) BioMarin Pharmaceuticals Inc. (BMRN) Cellectis, Inc. (CLLS) Bluebird bio, Inc. (BLUE) Chimerix, Inc. (CMRX) Calithera Biosciences (CALA) CRISPR Therapeutics (CRSP) Cidara Therapeutics, Inc. (CDTX) DBV Technologies (DBVT) Dermira, Inc. (DERM) CytomyX Therapeutics, Inc. (CTMX) Galapagos (GLPG) Esperion Therapeutics (ESPR) Intercept Pharmaceuticals, Inc. (ICPT) GW Pharmaceuticals (GWPH) Macrogenics (MGNX) Keryx (KERX) Merus (MRUS) Lexicon Pharmaceuticals (LXRX) Molecular Partners (MOLN) Ligand Pharmaceuticals, Inc. (LGND) MyoKardia, Inc. (MYOK) Novavax (NVAX) Minerva Neurosciences , Inc. (NERV) Opthotech Corp (OPHT) Myovant Sciences, Inc. (MYOV) Ovid Therapeutics, Inc. (OVID) NantKwest Inc. (NK) Pharma Mar SA (PHM) Portola Pharmaceuticals (PTLA) Progenics Pharmaceuticals, Inc. (PGNX) Synlogic, Inc. (private) PTC Therapeutics, Inc. (PTCT) SQZ Biotechnologies (private) Reata Pharmaceuticals, Inc. (RETA) Theravance Biopharma, Inc. (TBPH) Vanda Pharmaceuticals, Inc. (VNDA) Voyager Therapeutics, Inc. (VYGR)

Xencor, Inc. (XNCR) Zymeworks, Inc. (ZYME)